Skip to main content
Premium Trial:

Request an Annual Quote

Danaher Forecasts 2012 Revenue Growth of 2 to 5 Percent

NEW YORK (GenomeWeb News) – Danaher today reaffirmed its fourth quarter guidance for 2011 and initiated its outlook for 2012.

The Washington, DC-based conglomerate, which acquired Beckman Coulter earlier this year for nearly $7 billion, reaffirmed that it expects its fourth-quarter adjusted earnings per share to be between $.75 and $.80.

It said that it expects its full-year 2012 EPS from continuing operations to be between $3.20 and $3.35 with core revenue growth from continuing operations of between 2 percent and 5 percent.

"We remain mindful that the recent macroeconomic headlines will likely make for a more challenging environment as we go forward," H. Lawrence Culp, president and CEO of Danaher, said in a statement.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.